Farther Finance Advisors’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $132K | Buy |
4,783
+1,238
| +35% | +$34.2K | ﹤0.01% | 1603 |
|
|
2025
Q1 | $96.3K | Buy |
3,545
+26
| +0.7% | +$706 | ﹤0.01% | 1560 |
|
|
2024
Q4 | $146K | Buy |
3,519
+2,615
| +289% | +$109K | 0.01% | 1141 |
|
|
2024
Q3 | $60.4K | Sell |
904
-178
| -16% | -$11.9K | ﹤0.01% | 1541 |
|
|
2024
Q2 | $125K | Buy |
1,082
+271
| +33% | +$31.4K | 0.01% | 1036 |
|
|
2024
Q1 | $85.6K | Buy |
811
+203
| +33% | +$21.4K | 0.01% | 994 |
|
|
2023
Q4 | $60.4K | Buy |
608
+362
| +147% | +$36K | ﹤0.01% | 980 |
|
|
2023
Q3 | $25.4K | Buy |
246
+106
| +76% | +$10.9K | ﹤0.01% | 1015 |
|
|
2023
Q2 | $17K | Buy |
140
+26
| +23% | +$3.16K | ﹤0.01% | 1047 |
|
|
2023
Q1 | $17.5K | Sell |
114
-41
| -26% | -$6.3K | 0.01% | 942 |
|
|
2022
Q4 | $27.8K | Buy |
+155
| New | +$27.8K | 0.01% | 628 |
|